Immune Signature to Predict Trastuzumab Benefit: Potential and Pitfalls

J Clin Oncol. 2015 Nov 1;33(31):3671-2. doi: 10.1200/JCO.2015.61.9650. Epub 2015 Aug 17.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / analysis*
  • Breast Neoplasms / genetics*
  • Breast Neoplasms / immunology*
  • Female
  • Humans
  • Molecular Targeted Therapy*
  • Receptor, ErbB-2 / analysis*

Substances

  • Antibodies, Monoclonal, Humanized
  • Biomarkers, Tumor
  • Receptor, ErbB-2